AQST
Aquestive Therapeutics is a specialty pharmaceutical company focused on developing and commercializing medicines delivered via PharmFilm, a proprietary oral film technology. The company emphasizes CNS and complex-molecule therapies and aims to solve therapeutic problems with patient-friendly delivery, including treatments for epilepsy and anaphylaxis. Headquartered in Warren, New Jersey, Aquestive operates globally to advance medicines that improve patient outcomes through innovative drug-delivery approaches.
No recent deals for this company.